Brenda Khan
On April 27, 2023, TruVision Health LLC recalled several dietary supplement products due to the presence of unapproved ingredients hordenine and/or octodrine/DMHA. Hordenine is possibly unsafe when ingested orally and may cause side effects such as increased heart rate, high blood pressure, jitteriness, nervousness, nausea, vomiting, and insomnia. Octodrine/DMHA is a stimulant that can lead to adverse effects such as rapid heart rate, myocardial contractility, and altered pain threshold. Consumers who have purchased the recalled products are advised to stop using them immediately and contact TruVision for a refund, exchange, or product disposal. This incident raises concerns about the safety of TruVision diet pills and the potential health risks associated with unapproved ingredients.
| Characteristics | Values |
|---|---|
| Recall Date | April 27, 2023 |
| Reason for Recall | Presence of unapproved dietary ingredients hordenine and/or octodrine/DMHA (1,5-Dimethylhexylamine) |
| Side Effects | Rapid heart rate, high blood pressure, jitteriness, nervousness, nausea, vomiting, chest pain, chills, diarrhea, dizziness, fatigue, headache, high heart rate, jitters, rash, stomach pain, sweating, insomnia, myocardial contractility, and pain threshold |
| Consumer Action | Stop using the products immediately and return them to TruVision Health LLC for a full refund, exchange, or discard |
| Contact Information | Truvy Customer Support: (855) 213-8788, Monday-Friday, 7:00 am – 6:00 pm MDT |
Explore related products
What You'll Learn
- TruVision Health recalls products due to potentially dangerous ingredients
- Hordenine and octodrine/DMHA are unapproved dietary ingredients
- Side effects of hordenine include rapid heart rate, high blood pressure, nausea, and vomiting
- Octodrine/DMHA is similar to dimethylamylamine (DMAA), which was removed from the market
- Consumers who have purchased recalled products should stop using them immediately and contact TruVision for a refund or exchange
TruVision Health recalls products due to potentially dangerous ingredients
On April 27, 2023, TruVision Health recalled various dietary supplement products due to the presence of compounds that the FDA considers "possibly unsafe" and which are not permitted to be sold as dietary supplements. The products contained hordenine and/or octodrine/DMHA (1,5-Dimethylhexylamine), which are sometimes sold as weight loss ingredients because they may enhance metabolism. Hordenine may have stimulant effects and side effects such as rapid heart rate, high blood pressure, jitteriness, nervousness, nausea, vomiting, and insomnia. Octodrine has been found to increase heart rate, myocardial contractility, and pain threshold in animal studies. There is no data on its metabolic pathway in humans, so its use during exercise is potentially dangerous.
DMHA is considered an unsafe food additive and does not meet the statutory definition of a dietary ingredient. Some consumers who have used the recalled products have reported experiencing chest pain, chills, diarrhea, dizziness, fatigue, headache, high blood pressure, high heart rate, jitters, nausea, nervousness, rash, stomach pain, sweating, and vomiting. The recalled products were packaged as capsules in blister packs and cardboard cartons or as stick packs in 30-count bags with the TruVision Health or Truvy brand name. They were sold online and distributed in the US, Canada, Australia, New Zealand, Germany, Ireland, and England.
Consumers who have purchased the affected products should immediately stop using them and return them to TruVision Health LLC for a full refund (excluding return shipping), an exchange, or they may discard the product. Consumers with questions can contact Truvy Customer Support by calling (855) 213-8788, Monday through Friday from 7:00 am to 6:00 pm MDT. This recall was initiated after an FDA inspection determined that the products were adulterated.
If you believe that a dietary supplement or other nutritional product has caused an unexpected or adverse reaction, you can report it to the U.S. FDA through their Safety Reporting Portal at https://www.safetyreporting.hhs.gov.
Anti-Inflammatory Diets: Natural Eczema Treatment?
You may want to see also
Explore related products
Hordenine and octodrine/DMHA are unapproved dietary ingredients
TruVision Health has recalled dietary supplement products due to the presence of the unapproved dietary ingredients hordenine and/or octodrine/DMHA (1,5-Dimethylhexylamine). Hordenine, which is possibly unsafe when ingested orally, may cause stimulating side effects such as rapid heart rate, high blood pressure, jitteriness, nervousness, nausea, vomiting, and insomnia. These adverse events are more likely to occur in sensitive sub-populations, such as pregnant women and individuals with cardiovascular disease. Currently, hordenine is not an approved dietary ingredient for supplements.
Octodrine or DMHA (1,5-Dimethylhexylamine) is similar to another stimulant called dimethylamylamine (DMAA), which was removed from the market in several countries due to safety concerns. Animal studies have shown that octodrine increases heart rate, myocardial contractility, and pain threshold. The FDA considers octodrine to be an unsafe food additive, and dietary supplements containing this ingredient are deemed adulterated under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
DMHA does not meet the definition of a dietary ingredient and is not approved for use in manufactured foods or dietary supplements. It is not considered safe for human consumption and is classified as an unsafe food additive by the FDA. As a result, supplements containing DMHA are considered adulterated and illegal for marketing.
The recall of TruVision Health products containing hordenine and/or octodrine/DMHA underscores the importance of regulatory oversight in the dietary supplement industry. Consumers who have purchased these recalled products should immediately discontinue their use and contact TruVision Health for a refund, exchange, or proper disposal. Additionally, consumers can report any adverse reactions experienced from dietary supplements to relevant authorities, such as the FDA in the United States, to aid in the identification and recall of potentially harmful products.
Exercise and Diet: The Weight Loss Dynamic Duo
You may want to see also
Explore related products
Side effects of hordenine include rapid heart rate, high blood pressure, nausea, and vomiting
TruVision Health has recalled several of its dietary supplement products due to the presence of hordenine and octodrine/DMHA, which are considered "possibly unsafe" by the FDA. Hordenine, in particular, has been associated with several side effects, including those mentioned in the prompt: rapid heart rate, high blood pressure, nausea, and vomiting.
Hordenine is a compound that is similar in structure to stimulants found in bitter orange. It is believed to stimulate the central nervous system, leading to an increased heart rate, blood pressure, and breathing rate. These effects are typically short-lived and require high doses. However, the safety profile of hordenine is uncertain, especially when taken orally.
The reported side effects of hordenine include:
- Rapid heart rate or increased heart rate: Hordenine may speed up the nervous system, resulting in a faster heartbeat. This effect is particularly notable when combined with other stimulant drugs.
- High blood pressure: Hordenine's stimulant properties may worsen pre-existing high blood pressure or hypertension.
- Nausea: Feelings of nausea are a common adverse reaction associated with hordenine consumption.
- Vomiting: In some cases, the stimulating effects of hordenine may lead to vomiting.
It is important to note that these side effects are not exhaustive, and individual sensitivities may vary. Hordenine may also cause additional adverse reactions, including jitteriness, nervousness, insomnia, seizures, and increased risk for kidney stones.
If you have experienced any unexpected or adverse reactions to TruVision products or other dietary supplements, it is recommended to report them to the FDA through their Safety Reporting Portal or to consumer advocacy groups like ConsumerLab.com.
Building Blocks of a Balanced Diet
You may want to see also
Explore related products
Octodrine/DMHA is similar to dimethylamylamine (DMAA), which was removed from the market
Octodrine, also known as dimethylhexylamine (DMHA), is a central nervous system stimulant. It is structurally similar to dimethylamylamine (DMAA). DMAA has been banned by many sports organisations and governments due to safety concerns. It has been associated with adverse health effects, including heart attacks and even death.
DMHA is also considered unsafe by the FDA, which issued warning letters to manufacturers of dietary supplements containing DMHA in 2019. The FDA deemed these products to be adulterated and illegal for marketing. Side effects of DMHA include hypertension, dyspnea, and hyperthermia.
Like DMAA, DMHA is a sympathomimetic stimulant. It was previously approved by the FDA as an inhalant to treat hypotension (low blood pressure) and was available under brand names such as Vaporpac and Tickle Tackle Inhaler. However, it is no longer available.
DMHA has also been found as an adulterant in sports supplements and is sold online as a designer drug. Its synthetic origin is confirmed by the presence of a reductive amination byproduct.
Octodrine/DMHA is specified as a prohibited substance in the World Anti-Doping Agency (WADA) Prohibited List due to its stimulant properties.
Diet 7UP: A Pepsi Product?
You may want to see also
Explore related products
Consumers who have purchased recalled products should stop using them immediately and contact TruVision for a refund or exchange
On April 27, 2023, TruVision Health LLC recalled a list of dietary supplement products due to the presence of unapproved dietary ingredients. These ingredients, hordenine and/or octodrine/DMHA (1,5-Dimethylhexylamine), are considered "possibly unsafe" by the FDA and are not permitted to be sold as dietary supplements. Hordenine may have negative side effects when taken by mouth, especially for sensitive sub-populations such as pregnant women and people with cardiovascular disease. These side effects include rapid heart rate, high blood pressure, jitteriness, nervousness, nausea, vomiting, and insomnia. Octodrine or DMHA is a stimulant that can cause similar adverse effects, including rapid heart rate, myocardial contractility, and pain threshold.
In light of this recall, consumers who have purchased the affected products should immediately stop using them and are urged to take the following steps:
- Return the products to TruVision Health LLC for a full refund, excluding return shipping costs.
- Contact Truvy Customer Support by calling (855) 213-8788, Monday through Friday, from 7:00 am to 6:00 pm MDT, for any questions or concerns.
- Exchange the products at the store of purchase.
- Report any unexpected or adverse reactions to dietary supplements to relevant organizations, such as ConsumerLab and the U.S. FDA through their Safety Reporting Portal.
It is important for consumers to prioritize their health and safety by discontinuing the use of recalled TruVision products immediately and taking the necessary steps to obtain a refund or exchange.
Boosting Alkaline in Your Diet: Simple Ways to Get Started
You may want to see also
Frequently asked questions
TruVision recalled their dietary supplement products due to the presence of unapproved dietary ingredients hordenine and/or octodrine/DMHA (1,5-Dimethylhexylamine).
Hordenine is possibly unsafe when taken by mouth and might cause stimulating side effects such as rapid heart rate, high blood pressure, jitteriness, nervousness, nausea, vomiting, or insomnia.
Octodrine or DMHA is a stimulant that causes negative side effects like rapid heart rate, myocardial contractility, and pain threshold.
Consumers who have purchased these products should stop using them immediately and return them to TruVision Health LLC for a full refund, an exchange, or discard them.
You can contact TruVision Health LLC by calling (855) 213-8788, Monday-Friday from 7:00 am – 6:00 pm MDT.
